Stifel Downgrades ProQR Therapeutics N.V. (PRQR) to Hold, Following Clinical Business Update
Tweet Send to a Friend
Stifel analyst Dae Gon Ha downgraded ProQR Therapeutics N.V. (NASDAQ: PRQR) from Buy to Hold with a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
